Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NYSE:RAD

Rite Aid (RAD) Stock Price, News & Analysis

Rite Aid logo

About Rite Aid Stock (NYSE:RAD)

Key Stats

Today's Range
N/A
50-Day Range
$0.39
$1.89
52-Week Range
N/A
Volume
5,426 shs
Average Volume
4.16 million shs
Market Capitalization
$34.71 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. The company operates through two segments, Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment sells prescription drugs and provides various other pharmacy services and an assortment of products comprising over-the-counter medications, health and beauty aids, personal care products, seasonal merchandise, cosmetics, household items, food and beverages, greeting cards, seasonal and seasonal merchandise, pet care, and a variety of other everyday and convenience products, as well as brand and generic prescription drugs; and a private brand product line. It also operates retail pharmacies and clinics; and offers healthcare services, including administering immunizations for COVID-19, the flu, shingles, and others; assists its customers with high blood pressure, cholesterol, and diabetes; provides guidance on combating obesity and tobacco addiction; and educates customers on managing medications and potential side effects. The Pharmacy Services segment provides integrated suite of pharmacy benefit management (PBM) offerings, including technology solutions, mail delivery services, specialty pharmacy, network and rebate administration, claims adjudication, and pharmacy discount programs, as well as drug benefits under the federal government's Medicare Part D program and insurance offerings for individuals and groups. This segment serves health plans, commercial employers, labor groups, and state and local governments. In addition, it offers its products through online retail site. Rite Aid Corporation was founded in 1962 and is headquartered in Philadelphia, Pennsylvania.

Receive RAD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Rite Aid and its competitors with MarketBeat's FREE daily newsletter.

RAD Stock News Headlines

Rite Aid workers ratify three-year contract
Here’s how you could profit from the historic Trump rally
Ex-Wall Street CEO crushed the market this year... Giving his readers a chance to outperform the S&P by as much as 164%. Now he's saying Trump's landslide win is opening up a rare window of opportunity.
Rite Aid closures continue in Michigan, Ohio
See More Headlines

RAD Stock Analysis - Frequently Asked Questions

Rite Aid Co. (NYSE:RAD) issued its quarterly earnings data on Thursday, April, 20th. The company reported ($1.24) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.77) by $0.47. The business's quarterly revenue was up .5% compared to the same quarter last year.

Rite Aid shares reverse split before market open on Monday, April 22nd 2019. The 1-20 reverse split was announced on Wednesday, April 10th 2019. The number of shares owned by shareholders was adjusted after the closing bell on Friday, April 19th 2019. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Rite Aid subsidiaries include Bartell Drugs, Envision Pharmaceutical, RediClinic, Health Dialog, Edgehill Drugs, PCS Health Systems, Harco, and others.

Based on aggregate information from My MarketBeat watchlists, some other companies that Rite Aid investors own include BMO Capital Markets (), Stifel Nicolaus (), Wunderlich (), Standpoint Research (), Duncan Williams (), Soleil Securities () and Sterne Agee CRT ().

Company Calendar

Last Earnings
4/20/2023
Today
12/04/2024
Fiscal Year End
2/28/2025

Industry, Sector and Symbol

Industry
Drug stores & proprietary stores
Sub-Industry
Drug Retail
CUSIP
76775410
Employees
47,000
Year Founded
1968

Profitability

Net Income
$-749,940,000.00
Pretax Margin
-4.02%

Debt

Sales & Book Value

Annual Sales
$24.09 billion
Book Value
($11.35) per share

Miscellaneous

Free Float
55,800,000
Market Cap
$34.71 million
Optionable
Optionable
Beta
1.25

Social Links

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NYSE:RAD) was last updated on 12/4/2024 by MarketBeat.com Staff
From Our Partners